Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 10, 2024
Comparison of brief olfactory and cognitive assessments to neuroimaging biomarkers in the prediction of cognitive decline and dementia in the MCSA cohortDavangere P Devanand, Seonjoo Lee, José A Luchsinger, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 23, 2016
Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summaryGil D Rabinovici, Jason Karlawish, David Knopman, et al.BMC Health Services Research|May 30, 2026
Healthcare utilization and morbidity preceding a dementia classification: the Atherosclerosis Risk in Communities (ARIC) studyMeng Pan, Virginia Pate, David Knopman, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 4, 2008
The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollmentJason Karlawish, Scott Y H Kim, David Knopman, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 17, 2008
Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trialsJason Karlawish, Scott Y H Kim, David Knopman, et al.International Journal of Molecular Sciences|April 12, 2019
Plasma Metabolites Associated with Brain MRI Measures of Neurodegeneration in Older Adults in the Atherosclerosis Risk in Communities⁻Neurocognitive Study (ARIC-NCS)Danni Li, Jeffrey R Misialek, Clifford R Jack, et al.Neuroepidemiology|November 2, 2023
Timing of Cognitive Test Score Decline Prior to Incident Dementia Diagnosis in Blacks and Whites: The Atherosclerosis Risk in Communities Neurocognitive StudyYunzhi Wang, A Richey Sharrett, Andrea L C Schneider, et al.Neurobiology of Aging|May 26, 2020
Associations between cerebrospinal fluid total phosphatidylcholines, neurodegeneration, cognitive decline, and risk of mild cognitive impairment in the Mayo Clinic Study of AgingDanni Li, Clinton Hagen, Hai H Bui, et al.Neurology|January 30, 2015
Smoking and white matter hyperintensity progression: the ARIC-MRI StudyMelinda C Power, Jennifer A Deal, A Richey Sharrett, et al.Journal of the International Neuropsychological Society : JINS|August 26, 2004
Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's diseaseJulie A Testa, Robert J Ivnik, Bradley Boeve, et al.Pageof 11